Friday, October 11, 2024
wellness India Expo
Home Tags Pharmaceutical industry

Tag: pharmaceutical industry

BD and ten23 health collaborate to enhance prefillable syringe traceability with...

The new RFID solution aims to improve efficiency and traceability in the pharmaceutical fill & finish process

Parexel expands real-world research capabilities with new leadership

Mike D’Ambrosio appointed as Senior Vice President, Global Head of Real World Research, to enhance evidence-based approaches

Wanbury Limited names Prakash Venkatraman as new API division President

With 3 decades of experience in API operations and global sales, Venkatraman is set to lead Wanbury’s strategic growth in the API sector

Orchid Pharma posts 169% year-on-year PAT growth in Q1 FY 2024-25

Strategic initiatives and strong market presence propel continued success in the global pharmaceutical industry

Lupin’s revenue climbs 16.3% to INR 55,143 million in Q1 FY2025

Lupin Limited posts impressive gains with EBITDA rising by 48.9% and profit after tax nearly doubling compared to the previous year

Agilisium earns AWS Life Sciences Competency Status, joining elite group of...

Agilisium's innovative GenAI-powered solutions recognized for transforming pharmaceutical R&D and accelerating drug discovery

Orchid Pharma makes key appointments for its newly opened AMR division

The company has appointed Dr. Prabhu Vinayagam as Medical Advisor for its newly formed division, Orchid AMS, and hired Amitabh Mazumdar as GM- Sales & Marketing.

Orchid Pharma and Cipla to launch antibiotic Cefepime-Enmetazobactam in India

The partnership aims to address antimicrobial resistance through the rapid deployment of novel treatments for serious infections

Global experts highlight tech and quality at IPA’s Pharma Summit 2024

The two-day summit brought together industry leaders and regulators to discuss strategic priorities, regulatory reforms, and the future of pharmaceutical manufacturing

Lupin acquires Sanofi brands Aarane and Nalcrom in Europe and Canada

The strategic acquisition aims to bolster Lupin's global presence in respiratory and gastrointestinal care, enhancing its specialty pharmaceuticals portfolio